A Retrospective, nonrandomized study analyzing clinical and treatment characteristics of children with chronic anterior uveitis who require ABT (abatacept, tocilizumab, and/or golimumab)
Latest Information Update: 13 Dec 2022
At a glance
- Drugs Abatacept (Primary) ; Golimumab (Primary) ; Tocilizumab (Primary) ; Methotrexate; Tumour necrosis factor inhibitors
- Indications Anterior uveitis
- Focus Therapeutic Use
Most Recent Events
- 13 Dec 2022 New trial record
- 01 Dec 2022 Results published in the American Journal of Ophthalmology